Rapid POC Assays

About Sedia Biosciences

Sedia Biosciences is a US-based diagnostics company specializing in tools for disease surveillance and point-of-care testing, with a strong emphasis on global health access. The company has established market leadership with its HIV recency assays, which are critical for public health organizations to estimate HIV incidence and allocate resources. Beyond HIV, Sedia is developing a broader portfolio of rapid infectious disease diagnostics and innovative specimen collection devices. Its business model integrates product sales across diagnostics, devices, and genomics services, targeting both resource-rich and resource-limited settings.

Therapeutic Areas